Table of Contents
List of Tables
List of Figures
Epigenomics AG Company Overview
Epigenomics AG Company Snapshot
Epigenomics AG Pipeline Products and Ongoing Clinical Trials Overview
Epigenomics AG – Pipeline Analysis Overview
Business Description
Epigenomics AG – Key Facts
Epigenomics AG – Major Products and Services
Epigenomics AG Pipeline Products by Development Stage
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG Pipeline Products Overview
Biomarker PITX2 – Prostate Cancer Prognosis
Biomarker PITX2 – Prostate Cancer Prognosis Product Overview
Blood – Based Lung Cancer Test
Blood – Based Lung Cancer Test Product Overview
Epi proColon 1.0
Epi proColon 1.0 Product Overview
HCCBloodTest
HCCBloodTest Product Overview
HCCBloodTest Clinical Trial
NGS Panel – Bladder Cancer
NGS Panel – Bladder Cancer Product Overview
NGS Panel – Breast Cancer
NGS Panel – Breast Cancer Product Overview
NGS Panel – Colorectal Cancer
NGS Panel – Colorectal Cancer Product Overview
NGS Panel – Lung Cancer
NGS Panel – Lung Cancer Product Overview
NGS Panel – Ovarian Cancer
NGS Panel – Ovarian Cancer Product Overview
NGS Panel – Prostate Cancer
NGS Panel – Prostate Cancer Product Overview
Epigenomics AG – Key Competitors
Epigenomics AG – Key Employees
Epigenomics AG – Key Employee Biographies
Epigenomics AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Epigenomics AG, Recent Developments
Nov 29, 2019: New micro-simulation study in cancer medicine finds Epi proColon provides clinically meaningful reductions in incidence and mortality of colorectal cancer
Nov 19, 2019: Epigenomics reports financial results for the first nine months 2019
Aug 07, 2019: Epigenomics highlights operational achievements and reports financial results for first six months 2019
Jul 24, 2019: Study published in American Health Drug Benefits suggests that non-invasive screening methods, including Epi proColon, could be a cost-effective option to help achieve target U.S. colorectal cancer screening rates
Jul 11, 2019: Epigenomics receives MedTech Outlook’s 2019 top 10 in-vitro diagnostics award
Jun 17, 2019: New clinical data support the utility of Epi proColon blood test for colorectal cancer screening in patients with Lynch Syndrome, the most common hereditary CRC Syndrome
May 19, 2019: New report shows CRC screening rates increased when a medically underserved population is offered Epi proColon Blood Test
May 09, 2019: Epi proColon receives the 2019 Excellence in Molecular Diagnostics Award
May 08, 2019: Epigenomics announces 2019 first quarter financial results
May 03, 2019: CMS accepts Epigenomics’ application for NCD review
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
Epigenomics AG Pipeline Products and Ongoing Clinical Trials Overview
Epigenomics AG Pipeline Products by Equipment Type
Epigenomics AG Pipeline Products by Indication
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG, Key Facts
Epigenomics AG, Major Products and Services
Epigenomics AG Number of Pipeline Products by Development Stage
Epigenomics AG Pipeline Products Summary by Development Stage
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG Ongoing Clinical Trials Summary
Biomarker PITX2 - Prostate Cancer Prognosis - Product Status
Biomarker PITX2 - Prostate Cancer Prognosis - Product Description
Blood - Based Lung Cancer Test - Product Status
Blood - Based Lung Cancer Test - Product Description
Epi proColon 1.0 - Product Status
Epi proColon 1.0 - Product Description
HCCBloodTest - Product Status
HCCBloodTest - Product Description
HCCBloodTest - A Multi-center Validation and Development Study of Methylated Cell-free DNA Biomarkers to Aid in the Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
NGS Panel - Bladder Cancer - Product Status
NGS Panel - Bladder Cancer - Product Description
NGS Panel - Breast Cancer - Product Status
NGS Panel - Breast Cancer - Product Description
NGS Panel - Colorectal Cancer - Product Status
NGS Panel - Colorectal Cancer - Product Description
NGS Panel - Lung Cancer - Product Status
NGS Panel - Lung Cancer - Product Description
NGS Panel - Ovarian Cancer - Product Status
NGS Panel - Ovarian Cancer - Product Description
NGS Panel - Prostate Cancer - Product Status
NGS Panel - Prostate Cancer - Product Description
Epigenomics AG, Key Employees
Epigenomics AG, Key Employee Biographies
Epigenomics AG, Subsidiaries
Glossary